A26G (p.Ala26Gly) variant of MAP2K1 (Q02750)
A26G (p.Ala26Gly) in MAP2K1 (Q02750) is a protein-truncating change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.41 / 1. The record also includes population frequency data, experimental measurements, published literature, and structural context.
A26G (p.Ala26Gly) variant details
- p.Ala26Gly
- gnomAD 15-66387422-TGC-T
- Frameshift
- Variant Prioritization Score for Impact Estimate 0.408
- CADD 32.00
- Population evidence available
- Structural context available
- Dabrafenib and Cetuximab HT-29 cells, base editing z-scores (predicted consequen: score 0.108
- Literature evidence available